Clinical Trials Browser

Phase 2 × Colitis × Clear all

NCT04305145 2026-01-29

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Phase 2 Active not recruiting

Colitis, Melanoma, Skin Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT02814864 2021-08-03

PRISME

Phase 2 Unknown

Colitis, Diarrhea, Hemorrhage

NCT00533078 2015-07-23

LUNCH1

Phase 2 Completed

Colitis, Hyperphagia, Infections, Neutropenia, Mucositis

NCT00676832 2010-09-29

Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis

Phase 2 Completed

Colitis, Colitis, Ulcerative, Lymphoma, Follicular, Ulcer